Assuming range is required, the following results were found.

  • Biogen Strengthens MS & SMA Portfolio as Competition Lurks - Yahoo Finance

    Biogen, Inc. BIIB has a strong position in the multiple sclerosis (MS) market with a wide range of products including Avonex, Tysabri, Tecfidera and Plegridy. It is working on strengthening its position further by bringing new treatments. In November...

    https://mschristian.org/index.php/blog/biogen-strengthens-ms-sma-portfolio-as-competition-lurks-yahoo-finance
  • Prescription digital therapeutics: reimagining disease treatment - STAT

    authorization by the Food and Drug Administration. Prescription digital therapeutics are being developed for an astounding range of conditions, from schizophrenia and multiple sclerosis to chronic insomnia. In January of this year, my company, Pear...

    https://mschristian.org/index.php/blog/prescription-digital-therapeutics-reimagining-disease-treatment-stat
  • Fooling nerve cells into acting normal

    Discovery could inform future studies related to spinal cord injuries, multiple sclerosis and epilepsy Date:Source:University of Missouri-ColumbiaSummary:Scientists have discovered that a neuron's own electrical signal, or voltage, can indicate whether...

    https://mschristian.org/index.php/blog/fooling-nerve-cells-into-acting-normal
  • Purdy gets appointed as COO at Turning Point Brands

    Point Brands has promoted Graham A. Purdy to chief operating officer. Since joining the company in 2004, Purdy has held a range of leadership positions. Among other accomplishments, he built and ran the company’s sales organization, launched the Nu-X...

    https://mschristian.org/index.php/blog/purdy-gets-appointed-as-coo-at-turning-point-brands
  • MS Symptoms - Learn to recognize and manage the possible symptoms of MS, which range from mild to severe.

    MS Keywords: Fatigue; Pain; Gait (Walking), Cognition; Bladder, Bowel, Vision, Sexual Problems and Depression MS symptoms are variable and unpredictable. No two people have exactly the same symptoms, and each person’s symptoms can change or fluctuate...

    https://mschristian.org/index.php/blog/ms-symptoms-learn-to-recognize-and-manage-the-possible-symptoms-of-ms-which-range-from-mild-to-severe
  • Paul Mirabella Joins CorTechs Labs' Board of Directors - Business Wire

    involved in developing imaging solutions to reduce radiation exposure as well as artificial intelligence applications in a range of healthcare sectors, with a current focus in neurology. Previously, he served as president and CEO of GE Healthcare Global...

    https://mschristian.org/index.php/blog/paul-mirabella-joins-cortechs-labs-board-of-directors-business-wire
  • Athletico Physical Therapy Opens in Sylvania - P&T Community

    testing and more.Occupational/hand therapy – Our occupational and handtherapists can help improve your mobility and range of motion. These clinicians are at the top of their field, averaging more than 18 years of experience and holding the highest level...

    https://mschristian.org/index.php/blog/athletico-physical-therapy-opens-in-sylvania-p-t-community
  • The pulling power of MS - MS Trust

    The pulling power of MS, by Martin Baum People with MS report such a wide range of symptoms, that it's unlikely that any two people will have the same the experience. In his latest blog, Martin Baum talk's about a lesser know symptom, where he is...

    https://mschristian.org/index.php/blog/the-pulling-power-of-ms-ms-trust
  • MS Symptoms: Fatigue, Numbness, Balance Problems, and More

    fibers, disrupting the flow of electrical impulses throughout the nervous system. This nerve damage can lead to a broad range of MS symptoms, from blurred vision to numbness to weakness to loss of balance and more. For people with relapsing-remitting...

    https://mschristian.org/index.php/blog/ms-symptoms-fatigue-numbness-balance-problems-and-more
  • Global Multiple Sclerosis Drugs Production Market Share, Revenue, and Average Price by Manufacturers Shared in a Latest Research Report - Market Research Writeup

    and spinal cord are damaged. This damage disrupts the ability of parts of the nervous system to communicate, resulting in a range of signs and symptoms, including physical, mental, and sometimes psychiatric problems. Access Report Details at:...

    https://mschristian.org/index.php/blog/global-multiple-sclerosis-drugs-production-market-share-revenue-and-average-price-by-manufacturers-shared-in-a-latest-research-report-market-research-writeup
  • Novel PET imaging agent could help guide therapy for brain diseases

    that are too high can cause cell death. Medications that block NMDA receptors are therefore used for the treatment of a wide range of neurological conditions from depression, neuropathic pain and schizophrenia to ischemic stroke and diseases causing...

    https://mschristian.org/index.php/blog/novel-pet-imaging-agent-could-help-guide-therapy-for-brain-diseases
  • Stretching for People with MS—An Illustrated Manual (.pdf)

    Provided by #TheNationalMSSociety Illustrated manual showing range of motion, stretching, and balance exercises for at-home program. By Beth E. Gibson, PT. (last updated October 2016) Download Brochure...

    https://mschristian.org/index.php/blog/stretching-for-people-with-ms-an-illustrated-manual-pdf
  • Research Project 3TR To Use Breath Biopsy, Improve Immune-mediated Disease Management - Technology Networks

    out to fundamentally increase knowledge of the molecular pathways and mechanisms linked to response and non-response to a range of therapies. The work falls within and across seven different immune-mediated, allergic and inflammatory diseases - systemic...

    https://mschristian.org/index.php/blog/research-project-3tr-to-use-breath-biopsy-improve-immune-mediated-disease-management-technology-networks
  • Boys' IQ Tied to Endocrine Disruptor Exposure in Utero

    This link equated to a 1.9-point (95% CI -3.6 to -0.2) decline in IQ for boys at age 7 years for every one interquartile range higher of exposure in mothers, they wrote in Environment International. However, girls didn't appear to have any link between...

    https://mschristian.org/index.php/blog/boys-iq-tied-to-endocrine-disruptor-exposure-in-utero
  • Vitamin D no defense against dementia

    review of over 70 pre-clinical and clinical studies, Ms Iacopetta investigated the role of vitamin D across a wide range of neurodegenerative diseases. "Past studies had found that patients with a neurodegenerative disease tended to have lower levels of...

    https://mschristian.org/index.php/blog/vitamin-d-no-defense-against-dementia
  • Association Between Serum Neurofilament Light Chain Levels and Long-term Disease Course Among Patients With Multiple Sclerosis Followed up for 12 Years

    for 5 years, then at different time points for up to 12 years, with a median follow-up duration of 10 (interquartile range, 7-11) years. Serum NFL levels were measured using a sensitive single molecule array platform and compared with clinical and...

    https://mschristian.org/index.php/blog/association-between-serum-neurofilament-light-chain-levels-and-long-term-disease-course-among-patients-with-multiple-sclerosis-followed-up-for-12-years
  • Studies Report on Efforts to Optimize Rituximab in MS, NMOSD - The Center for Biosimilars

    for the 2 groups. They found that, among patients treated with the standard approach, the mean annual relapse rate was 0.35 (range, 0-1.6). Among the patients who were treated with the optimized approach, the mean annual relapse rate was 0.04 (range,...

    https://mschristian.org/index.php/blog/studies-report-on-efforts-to-optimize-rituximab-in-ms-nmosd-the-center-for-biosimilars
  • Genentech’s Satralizumab Significantly Reduced Relapse Risk in Second Positive Phase III Study for Neuromyelitis Optica Spectrum Disorder

    an add-on therapy and now as a monotherapy, are exciting to see, and importantly, satralizumab achieved efficacy in a broad range of NMOSD patients, reflective of what we see in our everyday practice. Satralizumab targets the IL-6 receptor, potentially...

    https://mschristian.org/index.php/blog/genentech-s-satralizumab-significantly-reduced-relapse-risk-in-second-positive-phase-iii-study-for-neuromyelitis-optica-spectrum-disorder
  • #ECTRIMS2019 - Longer DMT Use and Female Sex Seen to Protect Against SPMS Conversion - Multiple Sclerosis News Today

    11.96 years, patients’ age at the time of transition was a median of 44.0 years, and they had a median EDSS score of 4.5 (range, 3.5 to 6). The median time to reach EDSS 6 after SPMS onset was 4.08 years. Based on the algorithm, these values changed....

    https://mschristian.org/index.php/blog/ectrims2019-longer-dmt-use-and-female-sex-seen-to-protect-against-spms-conversion-multiple-sclerosis-news-today
  • What are the best exercises for MS?

    Table of contents Exercise has a range of benefits for people with multiple sclerosis. It can, for example, help improve strength and mobility and boost mental well-being. In previous years, doctors recommended that people with multiple sclerosis (MS)...

    https://mschristian.org/index.php/blog/what-are-the-best-exercises-for-ms

Results 1 - 20 of 33
 
 

Follow Us on Twitter

Follow Us On Twitter - Image